![](/img/cover-not-exists.png)
Risk of Serious Infection Associated with Agents that Target T-Cell Activation and Interleukin-17 and Interleukin-23 Cytokines
Shoor, StanfordVolume:
34
Journal:
Infectious Disease Clinics of North America
DOI:
10.1016/j.idc.2020.02.001
Date:
June, 2020
File:
PDF, 356 KB
2020